SCCT Feature: TeraRecon CEO touts advanced viz strategies for low-dose CT acquisitions
TeraRecon, a company specializing in advanced image processing and 3D visualization techniques, showcased its latest iteration of Aquarius iNtuition (4.4) software, with a special emphasis on low-dose scanning strategies, at the annual meeting of the Society of Cardiovascular Computed Tomography (SCCT) held last week in Orlando, Fla.
The push among cardiac CT imagers has been to lower the radiation dose as much as possible, while still achieving optimal diagnostic quality. Some low-dose strategies, however, accept a certain amount of noise. TeraRecon is aiming to fill those gaps.
"If the software is capable of processing low-dose scans, then high-dose scans are not required, so the software itself has a direct impact on reduction of patient dose," Robert Taylor, PhD, TeraRecon's president and CEO, told Cardiovascular Business News.
"Our software has been designed to work with lower-dose scans, which are inherently noisier, to find the centerlines, vessel walls and ventricle boundaries for cardiac function. We have some experience that our software does a better job than competitive software, such that if the competitor's 3D software is used, a higher dose scan is required to obtain an evaluable study," Taylor said.
iNtuition 4.4 provides physicians remote access to cardiovascular clinical tools, automation features and reading workflows which are made available throughout the healthcare enterprise and beyond through thin-client servers.
The company also has augmented the workflow and reporting capabilities of its 4.4 software to achieve enhanced compliance with the recently-released SCCT reporting guidelines for interpreting and reporting Coronary CTA, according to Taylor.
The push among cardiac CT imagers has been to lower the radiation dose as much as possible, while still achieving optimal diagnostic quality. Some low-dose strategies, however, accept a certain amount of noise. TeraRecon is aiming to fill those gaps.
"If the software is capable of processing low-dose scans, then high-dose scans are not required, so the software itself has a direct impact on reduction of patient dose," Robert Taylor, PhD, TeraRecon's president and CEO, told Cardiovascular Business News.
"Our software has been designed to work with lower-dose scans, which are inherently noisier, to find the centerlines, vessel walls and ventricle boundaries for cardiac function. We have some experience that our software does a better job than competitive software, such that if the competitor's 3D software is used, a higher dose scan is required to obtain an evaluable study," Taylor said.
iNtuition 4.4 provides physicians remote access to cardiovascular clinical tools, automation features and reading workflows which are made available throughout the healthcare enterprise and beyond through thin-client servers.
The company also has augmented the workflow and reporting capabilities of its 4.4 software to achieve enhanced compliance with the recently-released SCCT reporting guidelines for interpreting and reporting Coronary CTA, according to Taylor.